BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20566214)

  • 21. Superparamagnetic perfluorooctylbromide nanoparticles as a multimodal contrast agent for US, MR, and CT imaging.
    Li A; Zheng Y; Yu J; Wang Z; Yang Y; Wu W; Guo D; Ran H
    Acta Radiol; 2013 Apr; 54(3):278-83. PubMed ID: 23319724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging.
    Vuu K; Xie J; McDonald MA; Bernardo M; Hunter F; Zhang Y; Li K; Bednarski M; Guccione S
    Bioconjug Chem; 2005; 16(4):995-9. PubMed ID: 16029042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-beta fibrils detection and removal by a magnetic field.
    Skaat H; Margel S
    Biochem Biophys Res Commun; 2009 Sep; 386(4):645-9. PubMed ID: 19559008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking.
    Hsiao JK; Tsai CP; Chung TH; Hung Y; Yao M; Liu HM; Mou CY; Yang CS; Chen YC; Huang DM
    Small; 2008 Sep; 4(9):1445-52. PubMed ID: 18680095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles.
    Pittet MJ; Swirski FK; Reynolds F; Josephson L; Weissleder R
    Nat Protoc; 2006; 1(1):73-9. PubMed ID: 17406214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
    Al-Jamal WT; Al-Jamal KT; Bomans PH; Frederik PM; Kostarelos K
    Small; 2008 Sep; 4(9):1406-15. PubMed ID: 18711753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo imaging platform for tracking immunotherapeutic cells.
    Ahrens ET; Flores R; Xu H; Morel PA
    Nat Biotechnol; 2005 Aug; 23(8):983-7. PubMed ID: 16041364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.
    He X; Nie H; Wang K; Tan W; Wu X; Zhang P
    Anal Chem; 2008 Dec; 80(24):9597-603. PubMed ID: 19007246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High F-Content Perfluoropolyether-Based Nanoparticles for Targeted Detection of Breast Cancer by
    Zhang C; Moonshi SS; Wang W; Ta HT; Han Y; Han FY; Peng H; Král P; Rolfe BE; Gooding JJ; Gaus K; Whittaker AK
    ACS Nano; 2018 Sep; 12(9):9162-9176. PubMed ID: 30118590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microfluidic assembly of monodisperse, nanoparticle-incorporated perfluorocarbon microbubbles for medical imaging and therapy.
    Seo M; Gorelikov I; Williams R; Matsuura N
    Langmuir; 2010 Sep; 26(17):13855-60. PubMed ID: 20666507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional core–shell silica nanoparticles for highly sensitive (19)F magnetic resonance imaging.
    Matsushita H; Mizukami S; Sugihara F; Nakanishi Y; Yoshioka Y; Kikuchi K
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1008-11. PubMed ID: 24446255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbubbles loaded with nanoparticles: a route to multiple imaging modalities.
    Park JI; Jagadeesan D; Williams R; Oakden W; Chung S; Stanisz GJ; Kumacheva E
    ACS Nano; 2010 Nov; 4(11):6579-86. PubMed ID: 20968309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfluorocarbon-Based
    Akazawa K; Sugihara F; Nakamura T; Matsushita H; Mukai H; Akimoto R; Minoshima M; Mizukami S; Kikuchi K
    Angew Chem Int Ed Engl; 2018 Dec; 57(51):16742-16747. PubMed ID: 30375721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 19F magnetic resonance imaging of endogenous macrophages in inflammation.
    Temme S; Bönner F; Schrader J; Flögel U
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):329-43. PubMed ID: 22354793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons.
    Stoll G; Basse-Lüsebrink T; Weise G; Jakob P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):438-47. PubMed ID: 22422659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative (1)H MRI, (19)F MRI, and (19)F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles.
    Kok MB; de Vries A; Abdurrachim D; Prompers JJ; Grüll H; Nicolay K; Strijkers GJ
    Contrast Media Mol Imaging; 2011; 6(1):19-27. PubMed ID: 20648660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles for "two color"
    Koshkina O; White PB; Staal AHJ; Schweins R; Swider E; Tirotta I; Tinnemans P; Fokkink R; Veltien A; van Riessen NK; van Eck ERH; Heerschap A; Metrangolo P; Baldelli Bombelli F; Srinivas M
    J Colloid Interface Sci; 2020 Apr; 565():278-287. PubMed ID: 31978790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half-lives and sensitivity.
    Jacoby C; Temme S; Mayenfels F; Benoit N; Krafft MP; Schubert R; Schrader J; Flögel U
    NMR Biomed; 2014 Mar; 27(3):261-71. PubMed ID: 24353148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
    Caruthers SD; Cyrus T; Winter PM; Wickline SA; Lanza GM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):311-23. PubMed ID: 20049799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociation of
    Bouvain P; Flocke V; Krämer W; Schubert R; Schrader J; Flögel U; Temme S
    MAGMA; 2019 Feb; 32(1):133-145. PubMed ID: 30498884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.